Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardio Vascular Dynamics' (CVD) controlled angioplasty technology (CAT) catheters approved in Japan:

This article was originally published in Clinica

Executive Summary

Cardio Vascular Dynamics' (US) controlled angioplasty technology (CAT) catheter has been approved for marketing in Japan. The company's Japanese distributor, Fukuda Denshi, will begin marketing the catheters in the final quarter this year. The devices use CVD's Focal expansion technology to perform percutaneous transluminal coronary angioplasty using both low and high balloon inflation pressures within a single catheter. Eight CAT models, including both over-the-wire and rail-design catheters, have been approved in total in Japan. CVD's European manufacturing plant will produce the catheters for the Japanese market.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093224

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel